|
|
 |
|
Proceedings
Day 2 - Tuesday, September 23, 2003
Lead Optimization
Discussion Leader: Jonathan Burbaum, ActivX Biosciences
Using Comprehensive Metabolomics to Determine and Classify the Mode(s) of
Action of New Chemical Entities and their Relative Toxicity Risks
Dayan Goodenowe, Phenomenome Discoveries
Automated Approaches to the Detection and Characterization of
Pharmaceutical Metabolites by the Application of MS/MS Software Algorithms
Jonathan Josephs, Bristol-Myers Squibb
New Methods for Rapid Analysis of Radiocarbon-labeled Drugs
by Accelerator Mass Spectrometry
Paul L. Skipper, Massachusetts Institute of Technology
Roundtable Discussion
Reactive Xenobiotic Intermediates
Discussion Leader: Chung-Ping Yu, GlaxoSmithKline
A High Throughput LC-MS-MS Method for Screening Glutathione Conjugations Using Exact Mass Neutral Loss
Li Liang, GlaxoSmithKline
Reactive Intermediates in Drug Metabolism: Tools and Toxicology
Michael L. Schrag, Merck Research Laboratories
Mechanistic Investigation Into the Formation of Reactive Metabolites in Drug Discovery and Development
Jack Wang and Jim Wang, Wyeth Research
Roundtable Discussion
Compound Library Analysis and Profiling
Discussion Leader: Robyn A. Rourick, Kalypsys
Strategies for Predictive Library Rehearsal, Design and QC that Deliver High Quality Combinatorial Libraries
James Connelly, Aventis
Repository Compound Stability and Quality Studies in Support of Lead Discovery
Xueheng Cheng, Abbott Laboratories
Design and Implementation of Technologies to Purify 10,000 Samples Per Month
John Isbell, Genomics Institute of the Novartis Research Foundation
High Throughput Liquid Chromatography Systems for Compound Library Screening
Steve O'Connor, Nanostream
Roundtable Discussion
Conversion of Data to Information: Dissemination of Information to Drive Therapeutic Area Projects
Discussion Leader: Eric Milgram, Pfizer Global R&D
Visual Basic for Applications (VBA): A Powerful Tool for Automated Data Processing
Eric Milgram, Pfizer Global R&D
Data Transformation and Processing in CYP-Inhibition HTS Assays
Mingdan Wu, Aventis
Enabling Collaboration Across Multiple Disciplines to Accelerate Drug Discovery
Francois Mandeville, Agilent Technologies
Bringing Biology to Proteomics: Integration with Functional Genomics
Todd Pihl, Celera Genomics
Roundtable Discussion
Vendor/Exhibitor Session
Drug Discovery Technologies & Applications
Discussion Leaders: John D. Laycock, Amgen
Steven Eendhuizen and Alex Berhitu, Spark Holland Inc.
Zamas Lam, Quest Pharmaceutical Services
Michael Lebrun, MicroCal, LLC
Jeremy Kenseth, Andrea Bastin, and Dennis Tallman, CombiSep, Inc.
Megan Thurmond and Hank Hodgin, Alcott Chromatography
Chris Phillips, Nanostream
Remco van Soest, LC Packings/Dionex, Sunnyvale, CA
Jeff Jensen, Eksigent Technologies
Luke Roenneburg, Gilson, Inc.
Dragan Vuckovic, IONICS Mass Spectrometry Group
Gary Harland, Waters Corporation
Carsten Baessmann, Bruker Daltonik GmbH
Brian Musselman, SciMarket Strategies
Gary Paul, Thermo Electron Corporation
Julie Wingate, Applied Biosystems/MDS Sciex
Kathleen Anderson, Novatia
Kevin Turnbull, Advanced Chemistry Development, Inc.
John P. Helfrich, NuGenesis Technologies Corporation
Paul Corcoran, McKinley Scientific
Poster Sessions
Chairs: Mingdan Wu, Aventis and Mingshe Zhu, Bristol-Myers Squibb
- Structure Identification
- Bioanalysis and ADME Screening
- Pharmaceutical Profiling
- Data Analysis
- New Applications, Methodologies & Technologies
|
|